Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease

被引:116
作者
Kimura, Hiroshi [1 ]
Ito, Yoshinori [2 ]
Suzuki, Ritsuro [3 ]
Nishiyama, Yukihiro [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Virol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4668550, Japan
[3] Nagoya Univ, Sch Med, Dept HSCT Data Management, Nagoya, Aichi 4668550, Japan
关键词
D O I
10.1002/rmv.582
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Because Epstein-Barr virus (EBV) is ubiquitous and persists latently in lymphocytes, simply detecting EBV is insufficient to diagnose EBV-associated diseases. Therefore, measuring the EBV load is necessary to diagnose EBV-associated diseases and to explore EBV pathogenesis. Due to the diverse biology of EBV, the significance of measuring EBV DNA and the optimal type of specimen differ among EBV-associated diseases. Recent advances in molecular technology have enabled the EBV genome to be quantitated rapidly and accurately. Real-time polymerase chain reaction (PCR) is a rapid and reliable method to quantify DNA and is widely used not only as a diagnostic tool, but also as a management tool for EBV-associated diseases. However, each laboratory currently measures EBV load with its own "homebrew" system, and there is no consensus on sample type, sample preparation protocol, or assay units. The EBV real-time PCR assay system must be standardised for large-scale studies and international comparisons. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:305 / 319
页数:15
相关论文
共 115 条
[31]   Detection of herpesvirus DNA in the serum of immunocompetent children [J].
Hara, S ;
Kimura, H ;
Hoshina, Y ;
Tanaka, N ;
Nishikawa, K ;
Ihira, M ;
Yoshikawa, T ;
Morishima, T .
MICROBIOLOGY AND IMMUNOLOGY, 2002, 46 (03) :177-180
[32]   EPSTEIN-BARR VIRUS IN NASAL T-CELL LYMPHOMAS IN PATIENTS WITH LETHAL MIDLINE GRANULOMA [J].
HARABUCHI, Y ;
YAMANAKA, N ;
KATAURA, A ;
IMAI, S ;
KINOSHITA, T ;
MIZUNO, F ;
OSATO, T .
LANCET, 1990, 335 (8682) :128-130
[33]   Real time quantitative PCR [J].
Heid, CA ;
Stevens, J ;
Livak, KJ ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :986-994
[34]   Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus [J].
Hislop, Andrew D. ;
Taylor, Graham S. ;
Sauce, Delphine ;
Rickinson, Alan B. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :587-617
[35]   Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo [J].
Hochberg, D ;
Middeldorp, JM ;
Catalina, M ;
Sullivan, JL ;
Luzuriaga, K ;
Thorley-Lawson, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (01) :239-244
[36]   Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome [J].
Holmes, RD ;
Orban-Eller, K ;
Karrer, FR ;
Rowe, DT ;
Narkewicz, MR ;
Sokol, RJ .
TRANSPLANTATION, 2002, 74 (03) :367-372
[37]   Persistent Epstein-Barr virus infection: Unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients [J].
Hopwood, PA ;
Brooks, L ;
Parratt, R ;
Hunt, BJ ;
Maria, B ;
Alero, TJ ;
Magdi, Y ;
Crawford, DH .
TRANSPLANTATION, 2002, 74 (02) :194-202
[38]  
Hoshino Y, 1999, J IMMUNOL, V163, P5735
[39]   Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation [J].
Hoshino, Y ;
Kimura, H ;
Tanaka, N ;
Tsuge, I ;
Kudo, K ;
Horibe, K ;
Kato, K ;
Matsuyama, T ;
Kikuta, A ;
Kojima, S ;
Morishima, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (01) :105-111
[40]   Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils [J].
Hudnall, SD ;
Ge, YM ;
Wei, LX ;
Yang, NP ;
Wang, HQ ;
Chen, TS .
MODERN PATHOLOGY, 2005, 18 (04) :519-527